4//SEC Filing
van der Velden Peter 4
Accession 0001654954-20-000270
CIK 0001540159other
Filed
Jan 9, 7:00 PM ET
Accepted
Jan 10, 2:13 PM ET
Size
18.7 KB
Accession
0001654954-20-000270
Insider Transaction Report
Form 4
van der Velden Peter
Director10% Owner
Transactions
- Purchase
Common Share Warrants (Right to Buy)
2020-01-08+96,542→ 96,542 total(indirect: By IRA)Exercise: $4.80From: 2020-07-08Exp: 2023-07-08→ Common Shares (96,542 underlying) - Purchase
Common Shares
2020-01-08$3.20/sh+128,722$411,910→ 1,833,066 total(indirect: By IRA) - Purchase
Common Share Warrants (Right to Buy)
2020-01-08+8,928→ 8,928 total(indirect: By IRA)Exercise: $4.80From: 2020-07-08Exp: 2023-07-08→ Common Shares (8,928 underlying) - Purchase
Common Share Warrants (Right to Buy)
2020-01-08+5,952→ 5,952 total(indirect: By IRA)Exercise: $4.00From: 2020-07-08Exp: 2020-11-08→ Common Shares (5,952 underlying) - Purchase
Common Shares
2020-01-08$3.20/sh+11,903$38,090→ 169,502 total(indirect: By IRA) - Purchase
Common Share Warrants (Right to Buy)
2020-01-08+64,362→ 64,362 total(indirect: By IRA)Exercise: $4.00From: 2020-07-08Exp: 2020-11-08→ Common Shares (64,362 underlying)
Transactions
- Purchase
Common Shares
2020-01-08$3.20/sh+11,903$38,090→ 169,502 total(indirect: By IRA) - Purchase
Common Share Warrants (Right to Buy)
2020-01-08+5,952→ 5,952 total(indirect: By IRA)Exercise: $4.00From: 2020-07-08Exp: 2020-11-08→ Common Shares (5,952 underlying) - Purchase
Common Share Warrants (Right to Buy)
2020-01-08+96,542→ 96,542 total(indirect: By IRA)Exercise: $4.80From: 2020-07-08Exp: 2023-07-08→ Common Shares (96,542 underlying) - Purchase
Common Share Warrants (Right to Buy)
2020-01-08+64,362→ 64,362 total(indirect: By IRA)Exercise: $4.00From: 2020-07-08Exp: 2020-11-08→ Common Shares (64,362 underlying) - Purchase
Common Shares
2020-01-08$3.20/sh+128,722$411,910→ 1,833,066 total(indirect: By IRA) - Purchase
Common Share Warrants (Right to Buy)
2020-01-08+8,928→ 8,928 total(indirect: By IRA)Exercise: $4.80From: 2020-07-08Exp: 2023-07-08→ Common Shares (8,928 underlying)
Footnotes (5)
- [F1]The reported securities are included within 128,722 Common Shares purchased by the reporting person for $3.20 per Common Share. Each Common Share includes the purchase of Class A Warrants to purchase 0.75 of a Common Share, and Class B Warrants to purchase 0.50 of a Common Share.
- [F2]The reported securities are included within 11,903 Common Shares purchased by the reporting person for $3.20 per Common Share. Each Common Share includes the purchase of Class A Warrants to purchase 0.75 of a Common Share, and Class B Warrants to purchase 0.50 of a Common Share.
- [F3]This Form 4 is jointly filed by (i) Lumira Capital II, L.P. ("LCII LP"), (ii) Lumira Capital II (International), L.P. ("LCII INT LP"), (iii) Lumira Capital GP, L.P., (iv) Lumira GP Inc., (v) Lumira GP Holdings Co., and (vi) Lumira Capital Investment Management Inc. Lumira Capital GP, L.P., the general partners of which are Lumira GP Inc. and Lumira GP Holdings Co., is the general partner of LCII LP and LCII INT LP, and each of LCII LP and LCII INT LP is managed by Lumira Capital Investment Management Inc. Mr. van der Velden is an executive officer of Lumira GP Inc., Lumira GP Holdings Co., and Lumira Capital Investment Management Inc. Each of Lumira Capital GP, L.P., Lumira GP Inc., Lumira GP Holdings Co., Lumira Capital Investment Management Inc. and Mr. van der Velden may be deemed to beneficially own the shares held by LCII LP and LCII INT LP, but each disclaim beneficial ownership except to the extent of their pecuniary interest therein, if any.
- [F4]Consists of Class A Warrants to purchase Common Shares. The Class A Warrants are exercisable beginning on July 8, 2020 and expire on July 8, 2023.
- [F5]Consists of Class B Warrants to purchase Common Shares. The Class B Warrants are exercisable beginning on July 8, 2020 and expire on November 8, 2020.
Documents
Issuer
Edesa Biotech, Inc.
CIK 0001540159
Entity typeother
Related Parties
1- filerCIK 0001778046
Filing Metadata
- Form type
- 4
- Filed
- Jan 9, 7:00 PM ET
- Accepted
- Jan 10, 2:13 PM ET
- Size
- 18.7 KB